Skip to main content
Top
Published in: BMC Medical Genetics 1/2011

Open Access 01-12-2011 | Research article

Molecular and neurological characterizations of three Saudi families with lipoid proteinosis

Authors: Mustafa A Salih, Khaled K Abu-Amero, Saleh Alrasheed, Ibrahim A Alorainy, Lu Liu, John A McGrath, Lionel Van Maldergem, Yasser H Al-Faky, Adel H AlSuhaibani, Darren T Oystreck, Thomas M Bosley

Published in: BMC Medical Genetics | Issue 1/2011

Login to get access

Abstract

Background

Lipoid proteinosis is a rare autosomal recessive disease characterized by cutaneous and mucosal lesions and hoarseness appearing in early childhood. It is caused by homozygous or compound heterozygous mutations in the ECM1 gene. The disease is largely uncharacterized in Arab population and the mutation(s) spectrum in the Arab population is largely unknown. We report the neurologic and neuroradiologic characteristics and ECM1 gene mutations of seven individuals with lipoid proteinosis (LP) from three unrelated consanguineous families.

Methods

Clinical, neurologic, and neuro-ophthalmologic examinations; skin histopathology; brain CT and MRI; and sequencing of the fullECM1 gene.

Results

All seven affected individuals had skin scarring and hoarseness from early childhood. The two children in Family 1 had worse skin involvement and worse hoarseness than affected children of Families 2 and 3. Both children in Family 1 were modestly mentally retarded, and one had typical calcifications of the amygdalae on CT scan. Affected individuals in Families 2 and 3 had no grossneurologic, neurodevelopmental, or neuroimaging abnormalities. Skin histopathology was compatible with LP in all three families. Sequencing the full coding region of ECM1 gene revealed two novel mutationsin Family 1 (c.1300-1301delAA) and Family 2 (p.Cys269Tyr) and in Family 3 a previously described 1163 bp deletion starting 34 bp into intron 8.

Conclusions

These individuals illustrate the neurologic spectrum of LP, including variable mental retardation, personality changes, and mesial temporal calcificationand imply that significant neurologic involvement may be somewhat less common than previously thought. The cause of neurologic abnormalities was not clear from either neuroimaging or from what is known about ECM1 function. The severity of dermatologic abnormalities and hoarseness generally correlated with neurologic abnormalities, with Family 1 being somewhat more affected in all spheres than the other two families. Nevertheless, phenotype-genotype correlation was not obvious, possibly because of difficulty quantifying the neurologic phenotype and because of genetic complexity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Urbach E, Wiethe C: Lipoidosis cutis et mucosae. Virchow Arch [Path Anat]. 1929, 273: 285-319. 10.1007/BF02158983.CrossRef Urbach E, Wiethe C: Lipoidosis cutis et mucosae. Virchow Arch [Path Anat]. 1929, 273: 285-319. 10.1007/BF02158983.CrossRef
2.
go back to reference Hamada T, McLean WH, Ramsay M, Ashton GH, Nanda A, Jenkins T, Edelstein I, South AP, Bleck O, Wessagowit V, et al: Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum Mol Genet. 2002, 11 (7): 833-840. 10.1093/hmg/11.7.833.CrossRefPubMed Hamada T, McLean WH, Ramsay M, Ashton GH, Nanda A, Jenkins T, Edelstein I, South AP, Bleck O, Wessagowit V, et al: Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum Mol Genet. 2002, 11 (7): 833-840. 10.1093/hmg/11.7.833.CrossRefPubMed
3.
go back to reference Hamada T, Wessagowit V, South AP, Ashton GH, Chan I, Oyama N, Siriwattana A, Jewhasuchin P, Charuwichitratana S, Thappa DM, et al: Extracellular matrix protein 1 gene (ECM1) mutations in lipoid proteinosis and genotype-phenotype correlation. J Invest Dermatol. 2003, 120 (3): 345-350. 10.1046/j.1523-1747.2003.12073.x.CrossRefPubMed Hamada T, Wessagowit V, South AP, Ashton GH, Chan I, Oyama N, Siriwattana A, Jewhasuchin P, Charuwichitratana S, Thappa DM, et al: Extracellular matrix protein 1 gene (ECM1) mutations in lipoid proteinosis and genotype-phenotype correlation. J Invest Dermatol. 2003, 120 (3): 345-350. 10.1046/j.1523-1747.2003.12073.x.CrossRefPubMed
4.
go back to reference Sercu S, Zhang M, Oyama N, Hansen U, Ghalbzouri AE, Jun G, Geentjens K, Zhang L, Merregaert JH: Interaction of extracellular matrix protein 1 with extracellular matrix components: ECM1 is a basement membrane protein of the skin. J Invest Dermatol. 2008, 128 (6): 1397-1408. 10.1038/sj.jid.5701231. Errata (2009) 1129:1836-1837CrossRefPubMed Sercu S, Zhang M, Oyama N, Hansen U, Ghalbzouri AE, Jun G, Geentjens K, Zhang L, Merregaert JH: Interaction of extracellular matrix protein 1 with extracellular matrix components: ECM1 is a basement membrane protein of the skin. J Invest Dermatol. 2008, 128 (6): 1397-1408. 10.1038/sj.jid.5701231. Errata (2009) 1129:1836-1837CrossRefPubMed
5.
go back to reference Staut CC, Naidich TP: Urbach-Wiethe disease (Lipoid proteinosis). Pediatr Neurosurg. 1998, 28 (4): 212-214. 10.1159/000028653.CrossRefPubMed Staut CC, Naidich TP: Urbach-Wiethe disease (Lipoid proteinosis). Pediatr Neurosurg. 1998, 28 (4): 212-214. 10.1159/000028653.CrossRefPubMed
6.
go back to reference Newton FH, Rosenberg RN, Lampert PW, O'Brien JS: Neurologic involvement in Urbach-Wiethe's disease (lipoid proteinosis). A clinical, ultrastructural, and chemical study. Neurology. 1971, 21 (12): 1205-1213.CrossRefPubMed Newton FH, Rosenberg RN, Lampert PW, O'Brien JS: Neurologic involvement in Urbach-Wiethe's disease (lipoid proteinosis). A clinical, ultrastructural, and chemical study. Neurology. 1971, 21 (12): 1205-1213.CrossRefPubMed
7.
go back to reference Emsley RA, Paster L: Lipoid proteinosis presenting with neuropsychiatric manifestations. J Neurol Neurosurg Psychiatry. 1985, 48 (12): 1290-1292. 10.1136/jnnp.48.12.1290.CrossRefPubMedPubMedCentral Emsley RA, Paster L: Lipoid proteinosis presenting with neuropsychiatric manifestations. J Neurol Neurosurg Psychiatry. 1985, 48 (12): 1290-1292. 10.1136/jnnp.48.12.1290.CrossRefPubMedPubMedCentral
8.
go back to reference Siebert M, Markowitsch HJ, Bartel P: Amygdala, affect and cognition: evidence from 10 patients with Urbach-Wiethe disease. Brain. 2003, 126 (Pt 12): 2627-2637. 10.1093/brain/awg271.CrossRefPubMed Siebert M, Markowitsch HJ, Bartel P: Amygdala, affect and cognition: evidence from 10 patients with Urbach-Wiethe disease. Brain. 2003, 126 (Pt 12): 2627-2637. 10.1093/brain/awg271.CrossRefPubMed
9.
go back to reference Thornton HB, Nel D, Thornton D, van Honk J, Baker GA, Stein DJ: The neuropsychiatry and neuropsychology of lipoid proteinosis. J Neuropsychiatry Clin Neurosci. 2008, 20 (1): 86-92.CrossRefPubMed Thornton HB, Nel D, Thornton D, van Honk J, Baker GA, Stein DJ: The neuropsychiatry and neuropsychology of lipoid proteinosis. J Neuropsychiatry Clin Neurosci. 2008, 20 (1): 86-92.CrossRefPubMed
10.
go back to reference Sunyaev S, Ramensky V, Koch I, Lathe W, Kondrashov AS, Bork P: Prediction of deleterious human alleles. Hum Mol Genet. 2001, 10 (6): 591-597. 10.1093/hmg/10.6.591.CrossRefPubMed Sunyaev S, Ramensky V, Koch I, Lathe W, Kondrashov AS, Bork P: Prediction of deleterious human alleles. Hum Mol Genet. 2001, 10 (6): 591-597. 10.1093/hmg/10.6.591.CrossRefPubMed
11.
go back to reference Mongiat M, Fu J, Oldershaw R, Greenhalgh R, Gown AM, Iozzo RV: Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis. J Biol Chem. 2003, 278 (19): 17491-17499. 10.1074/jbc.M210529200.CrossRefPubMed Mongiat M, Fu J, Oldershaw R, Greenhalgh R, Gown AM, Iozzo RV: Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis. J Biol Chem. 2003, 278 (19): 17491-17499. 10.1074/jbc.M210529200.CrossRefPubMed
12.
go back to reference Smits P, Ni J, Feng P, Wauters J, Van Hul W, Boutaibi ME, Dillon PJ, Merregaert J: The human extracellular matrix gene 1 (ECM1): genomic structure, cDNA cloning, expression pattern, and chromosomal localization. Genomics. 1997, 45 (3): 487-495. 10.1006/geno.1997.4918.CrossRefPubMed Smits P, Ni J, Feng P, Wauters J, Van Hul W, Boutaibi ME, Dillon PJ, Merregaert J: The human extracellular matrix gene 1 (ECM1): genomic structure, cDNA cloning, expression pattern, and chromosomal localization. Genomics. 1997, 45 (3): 487-495. 10.1006/geno.1997.4918.CrossRefPubMed
13.
go back to reference Johnson MR, Wilkin DJ, Vos HL, Ortiz de Luna RI, Dehejia AM, Polymeropoulos MH, Francomano CA: Characterization of the human extracellular matrix protein 1 gene on chromosome 1q21. Matrix Biol. 1997, 16 (5): 289-292. 10.1016/S0945-053X(97)90017-2.CrossRefPubMed Johnson MR, Wilkin DJ, Vos HL, Ortiz de Luna RI, Dehejia AM, Polymeropoulos MH, Francomano CA: Characterization of the human extracellular matrix protein 1 gene on chromosome 1q21. Matrix Biol. 1997, 16 (5): 289-292. 10.1016/S0945-053X(97)90017-2.CrossRefPubMed
14.
go back to reference Wiest G, Lehner-Baumgartner E, Baumgartner C: Panic attacks in an individual with bilateral selective lesions of the amygdala. Arch Neurol. 2006, 63 (12): 1798-1801. 10.1001/archneur.63.12.1798.CrossRefPubMed Wiest G, Lehner-Baumgartner E, Baumgartner C: Panic attacks in an individual with bilateral selective lesions of the amygdala. Arch Neurol. 2006, 63 (12): 1798-1801. 10.1001/archneur.63.12.1798.CrossRefPubMed
15.
go back to reference Meenan FO, Bowe SD, Dinn JJ, McCabe M, McCullen O, Masterson JG, Towers RP: Lipoid proteinosis; a clinical, pathological and genetic study. Q J Med. 1978, 47 (188): 549-561.PubMed Meenan FO, Bowe SD, Dinn JJ, McCabe M, McCullen O, Masterson JG, Towers RP: Lipoid proteinosis; a clinical, pathological and genetic study. Q J Med. 1978, 47 (188): 549-561.PubMed
16.
go back to reference Van Hougenhouck-Tulleken W, Chan I, Hamada T, Thornton H, Jenkins T, McLean WH, McGrath JA, Ramsay M: Clinical and molecular characterization of lipoid proteinosis in Namaqualand, South Africa. Br J Dermatol. 2004, 151 (2): 413-423. 10.1111/j.1365-2133.2004.06076.x.CrossRefPubMed Van Hougenhouck-Tulleken W, Chan I, Hamada T, Thornton H, Jenkins T, McLean WH, McGrath JA, Ramsay M: Clinical and molecular characterization of lipoid proteinosis in Namaqualand, South Africa. Br J Dermatol. 2004, 151 (2): 413-423. 10.1111/j.1365-2133.2004.06076.x.CrossRefPubMed
17.
go back to reference Sercu S, Lambeir AM, Steenackers E, El Ghalbzouri A, Geentjens K, Sasaki T, Oyama N, Merregaert J: ECM1 interacts with fibulin-3 and the beta 3 chain of laminin 332 through its serum albumin subdomain-like 2 domain. Matrix Biol. 2009, 28 (3): 160-169. 10.1016/j.matbio.2009.02.003.CrossRefPubMed Sercu S, Lambeir AM, Steenackers E, El Ghalbzouri A, Geentjens K, Sasaki T, Oyama N, Merregaert J: ECM1 interacts with fibulin-3 and the beta 3 chain of laminin 332 through its serum albumin subdomain-like 2 domain. Matrix Biol. 2009, 28 (3): 160-169. 10.1016/j.matbio.2009.02.003.CrossRefPubMed
18.
go back to reference Sercu S, et al: The importance of the extracellular matrix protein1 (ECM1) as basement membrane protein in maintaining skin function. Textbook of Aging Skin. Edited by: Farage MA, Miller KW, Maibach HI. 2010, Berlin, Heidelberg Springer-Verlag, 77-91. full_text.CrossRef Sercu S, et al: The importance of the extracellular matrix protein1 (ECM1) as basement membrane protein in maintaining skin function. Textbook of Aging Skin. Edited by: Farage MA, Miller KW, Maibach HI. 2010, Berlin, Heidelberg Springer-Verlag, 77-91. full_text.CrossRef
19.
go back to reference Fujimoto N, Terlizzi J, Aho S, Brittingham R, Fertala A, Oyama N, McGrath JA, Uitto J: Extracellular matrix protein 1 inhibits the activity of matrix metalloproteinase 9 through high-affinity protein/protein interactions. Exp Dermatol. 2006, 15 (4): 300-307. 10.1111/j.0906-6705.2006.00409.x.CrossRefPubMed Fujimoto N, Terlizzi J, Aho S, Brittingham R, Fertala A, Oyama N, McGrath JA, Uitto J: Extracellular matrix protein 1 inhibits the activity of matrix metalloproteinase 9 through high-affinity protein/protein interactions. Exp Dermatol. 2006, 15 (4): 300-307. 10.1111/j.0906-6705.2006.00409.x.CrossRefPubMed
20.
go back to reference Wilczynski GM, Konopacki FA, Wilczek E, Lasiecka Z, Gorlewicz A, Michaluk P, Wawrzyniak M, Malinowska M, Okulski P, Kolodziej LR, et al: Important role of matrix metalloproteinase 9 in epileptogenesis. J Cell Biol. 2008, 180 (5): 1021-1035. 10.1083/jcb.200708213.CrossRefPubMedPubMedCentral Wilczynski GM, Konopacki FA, Wilczek E, Lasiecka Z, Gorlewicz A, Michaluk P, Wawrzyniak M, Malinowska M, Okulski P, Kolodziej LR, et al: Important role of matrix metalloproteinase 9 in epileptogenesis. J Cell Biol. 2008, 180 (5): 1021-1035. 10.1083/jcb.200708213.CrossRefPubMedPubMedCentral
21.
go back to reference Ching S, Zhang H, Chen Q, Quan N: Differential expression of extracellular matrix and adhesion molecule genes in the brain of juvenile versus adult mice in responses to intracerebroventricular administration of IL-1. Neuroimmunomodulation. 2007, 14 (1): 46-56. 10.1159/000107288.CrossRefPubMed Ching S, Zhang H, Chen Q, Quan N: Differential expression of extracellular matrix and adhesion molecule genes in the brain of juvenile versus adult mice in responses to intracerebroventricular administration of IL-1. Neuroimmunomodulation. 2007, 14 (1): 46-56. 10.1159/000107288.CrossRefPubMed
22.
go back to reference Hofer PA: Urbach-Wiethe disease (lipoglycoproteinosis; lipoid proteinosis; hyalinosis cutis et mucosae). A review. Acta Derm Venereol Suppl (Stockh). 1973, 53: 1-52. Hofer PA: Urbach-Wiethe disease (lipoglycoproteinosis; lipoid proteinosis; hyalinosis cutis et mucosae). A review. Acta Derm Venereol Suppl (Stockh). 1973, 53: 1-52.
23.
go back to reference Appenzeller S, Chaloult E, Velho P, de Souza EM, Araujo VZ, Cendes F, Li LM: Amygdalae calcifications associated with disease duration in lipoid proteinosis. J Neuroimaging. 2006, 16 (2): 154-156. 10.1111/j.1552-6569.2006.00018.x.CrossRefPubMed Appenzeller S, Chaloult E, Velho P, de Souza EM, Araujo VZ, Cendes F, Li LM: Amygdalae calcifications associated with disease duration in lipoid proteinosis. J Neuroimaging. 2006, 16 (2): 154-156. 10.1111/j.1552-6569.2006.00018.x.CrossRefPubMed
24.
go back to reference Goncalves FG, de Melo MB, de LMV, Barra FR, Figueroa RE: Amygdalae and striatum calcification in lipoid proteinosis. AJNR Am J Neuroradiol. 2010, 31 (1): 88-90. 10.3174/ajnr.A1699.CrossRefPubMed Goncalves FG, de Melo MB, de LMV, Barra FR, Figueroa RE: Amygdalae and striatum calcification in lipoid proteinosis. AJNR Am J Neuroradiol. 2010, 31 (1): 88-90. 10.3174/ajnr.A1699.CrossRefPubMed
25.
go back to reference Horev L, Wollina DU, Potikha T, Hafner A, Ingber A, Liu L, McGrath JA, Zlotogorski A: Lipoid proteinosis: identification of two novel mutations in the human ECM-1 gene and lack of genotype-phenotype correlation. Acta Derm Venereol. 2009, 89 (5): 528-529. 10.2340/00015555-0673.CrossRefPubMed Horev L, Wollina DU, Potikha T, Hafner A, Ingber A, Liu L, McGrath JA, Zlotogorski A: Lipoid proteinosis: identification of two novel mutations in the human ECM-1 gene and lack of genotype-phenotype correlation. Acta Derm Venereol. 2009, 89 (5): 528-529. 10.2340/00015555-0673.CrossRefPubMed
Metadata
Title
Molecular and neurological characterizations of three Saudi families with lipoid proteinosis
Authors
Mustafa A Salih
Khaled K Abu-Amero
Saleh Alrasheed
Ibrahim A Alorainy
Lu Liu
John A McGrath
Lionel Van Maldergem
Yasser H Al-Faky
Adel H AlSuhaibani
Darren T Oystreck
Thomas M Bosley
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2011
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/1471-2350-12-31

Other articles of this Issue 1/2011

BMC Medical Genetics 1/2011 Go to the issue